MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1609.44%
Quick Ratio
1609.44%
Cash Ratio
1589.00%
Debt to Asset Ratio
39.40%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Less accumulated depreciation
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Term loan
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
201,565
194,834
119,731
86,963
Prepaid expenses and other current assets
2,593
2,918
1,658
3,171
Total current assets
204,158
197,752
121,389
90,134
Total fixed assets
5,874
5,777
5,200
4,790
Less accumulated depreciation
3,872
3,702
3,558
3,427
Fixed assets, net
2,002
2,075
1,642
1,363
Lease right of use assets
1,475
1,569
1,661
1,750
Restricted cash
416
416
416
266
Other assets
98
108
87
85
Total assets
208,149
201,920
125,195
93,598
Accounts payable
5,154
3,036
1,129
1,118
Accrued expenses
6,981
3,473
7,334
5,149
Current portion of term loans
-
-
0
4,225
Current portion of lease liability
461
453
445
437
Warrant liabilities
-
-
0
0
Other current liabilities
89
89
89
-
Total current liabilities
12,685
7,051
8,997
10,929
Deferred revenue
45
67
89
-
Term loan
46,744
46,428
46,122
0
Other long-term debt
1,087
1,047
1,008
973
Lease liability, net of current portion
1,225
1,343
1,459
1,572
Warrant liabilities
20,233
7,955
15,598
-
Total liabilities
82,019
63,891
73,273
13,474
Common stock, 0.01 par value 150,000,000 shares authorized at june 30, 2026 and december 31, 2025 76,240,884 and 55,020,911 shares issued at june 30, 2026 and december 31, 2025, respectively 76,118,276 and 54,898,303 shares outstanding at june 30, 2026 and december 31, 2025, respectively
761
733
550
550
Treasury stock (at cost)
448
448
448
448
Additional paid-in capital
403,970
376,992
282,207
280,913
Accumulated deficit
-278,153
-239,248
-230,387
-200,891
Total stockholders' equity
126,130
138,029
51,922
80,124
Total liabilities and stockholders' equity
208,149
201,920
125,195
93,598
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$201,565K (100.19%↑ Y/Y)Prepaid expenses andother current assets$2,593K (-11.23%↓ Y/Y)Total fixed assets$5,874K (12.62%↑ Y/Y)Total current assets$204,158K (97.05%↑ Y/Y)Fixed assets, net$2,002K (20.75%↑ Y/Y)Lease right of useassets$1,475K (277.24%↑ Y/Y)Restricted cash$416K (56.39%↑ Y/Y)Other assets$98K (117.78%↑ Y/Y)Less accumulateddepreciation$3,872K (8.83%↑ Y/Y)Total assets$208,149K (96.43%↑ Y/Y)Total liabilities andstockholders' equity$208,149K (96.43%↑ Y/Y)Total stockholders'equity$126,130K (39.82%↑ Y/Y)Total liabilities$82,019K (420.49%↑ Y/Y)Accumulated deficit-$278,153K (-46.69%↓ Y/Y)Treasury stock (at cost)$448K (0.00%↑ Y/Y)Additional paid-in capital$403,970K (44.41%↑ Y/Y)Term loan$46,744K Warrant liabilities$20,233K Total currentliabilities$12,685K (-13.80%↓ Y/Y)Lease liability, netof current portion$1,225K (1077.88%↑ Y/Y)Other long-term debt$1,087K (15.76%↑ Y/Y)Deferred revenue$45K Common stock, 0.01 parvalue 150,000,000...$761K (38.62%↑ Y/Y)Accrued expenses$6,981K (61.67%↑ Y/Y)Accounts payable$5,154K (163.90%↑ Y/Y)Current portion of leaseliability$461K (-22.39%↓ Y/Y)Other currentliabilities$89K

Candel Therapeutics, Inc. (CADL)

Candel Therapeutics, Inc. (CADL)